SEC Comment Letter 0000000000-23-010524 to Ampio Pharmaceuticals, Inc. (AMPE) (CIK 0001411906)
Ampio Pharmaceuticals, Inc. (AMPE) (CIK 0001411906)
Date: Sept. 25, 2023 · CIK: 0001411906 · Accession: 0000000000-23-010524
AI Filing Summary & Sentiment
File numbers found in text: 333-274558
Letter
United States securities and exchange commission logo September 25, 2023 Michael A. Martino Chief Executive Officer Ampio Pharmaceuticals, Inc. 9800 Mount Pyramid Court, Suite 400 Englewood, CO 80112 Re:Ampio Pharmaceuticals, Inc. Registration Statement on Form S-3 Filed September 18, 2023 File No. 333-274558 Dear Michael A. Martino: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: April Hamlin, Esq.
Show Raw Text
United States securities and exchange commission logo
September 25, 2023
Michael A. Martino
Chief Executive Officer
Ampio Pharmaceuticals, Inc.
9800 Mount Pyramid Court, Suite 400
Englewood, CO 80112
Re:Ampio Pharmaceuticals, Inc.
Registration Statement on Form S-3
Filed September 18, 2023
File No. 333-274558
Dear Michael A. Martino:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: April Hamlin, Esq.